These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38907547)

  • 1. Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study.
    Vañó-Galván S; Figueras-Nart I; Artime E; Díaz-Cerezo S; Núñez M; Iglesias C; Artés M; Huete T
    Eur J Dermatol; 2024 Apr; 34(2):163-175. PubMed ID: 38907547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database.
    Hammadi AA; Parmar NV; Farghaly M; Dallal SA; Zayed MWA; Ebeid F; Subramanyam K; Ramachandrachar BC; Ahmed HM
    J Dermatol; 2024 Sep; 51(9):1157-1171. PubMed ID: 39051178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan's National Health Insurance Research Database.
    Tsai TF; Huang YH; Wei CY; Ng KJ; Newson RS; Lee TH; Shen D; Wang BCM; Tang CH
    Value Health Reg Issues; 2024 Sep; 43():101007. PubMed ID: 38865765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims.
    Senna M; Ko J; Tosti A; Edson-Heredia E; Fenske DC; Ellinwood AK; Rueda MJ; Zhu B; King B
    Adv Ther; 2021 Sep; 38(9):4646-4658. PubMed ID: 34292518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real world evidence: patients with alopecia areata in Italy.
    Perrone V; Sabatino S; Avitabile A; Dovizio M; Leogrande M; Degli Esposti L
    Ital J Dermatol Venerol; 2024 Apr; 159(2):182-189. PubMed ID: 38650498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
    Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E
    JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional and national epidemiology of alopecia areata: a systematic review and modelling study.
    Jeon JJ; Jung SW; Kim YH; Parisi R; Lee JY; Kim MH; Lee WS; Lee S
    Br J Dermatol; 2024 Aug; 191(3):325-335. PubMed ID: 38332643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, management and the associated burden of mental health illness, atopic and autoimmune conditions, and common infections in alopecia areata: protocol for an observational study series.
    Harries M; Macbeth AE; Holmes S; Thompson AR; Chiu WS; Gallardo WR; Messenger AG; Tziotzios C; de Lusignan S
    BMJ Open; 2021 Nov; 11(11):e045718. PubMed ID: 34785540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective.
    Fenske DC; Ding Y; Morrow P; Smith SG; Silver MK; Moynihan M; Manjelievskaia J
    J Manag Care Spec Pharm; 2023 Apr; 29(4):409-419. PubMed ID: 36989453
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data.
    Sinclair R; Eisman S; Song W; Heung B; Surian C; Lee CMY; Witcombe D
    Australas J Dermatol; 2023 Aug; 64(3):330-338. PubMed ID: 37408523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States.
    Mostaghimi A; Gandhi K; Done N; Ray M; Gao W; Carley C; Wang T; Swallow E; Sikirica V
    J Manag Care Spec Pharm; 2022 Apr; 28(4):426-434. PubMed ID: 35332790
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatments for alopecia areata: a network meta-analysis.
    Mateos-Haro M; Novoa-Candia M; Sánchez Vanegas G; Correa-Pérez A; Gaetano Gil A; Fernández-García S; Ortega-Quijano D; Urueña Rodriguez MG; Saceda-Corralo D; Bennouna-Dalero T; Giraldo L; Tomlinson J; Vaño-Galván S; Zamora J
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013719. PubMed ID: 37870096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional and national burden of alopecia areata and its associated diseases, 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019.
    Jang H; Park S; Kim MS; Yon DK; Lee SW; Koyanagi A; Kostev K; Shin JI; Smith L
    Eur J Clin Invest; 2023 Jun; 53(6):e13958. PubMed ID: 36692126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database.
    Campos-Alberto E; Hirose T; Napatalung L; Ohyama M
    J Dermatol; 2023 Jan; 50(1):37-45. PubMed ID: 36321512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of alopecia areata for managed care and payer stakeholders in the United States.
    King B; Pezalla E; Fung S; Tran H; Bourret JA; Peeples-Lamirande K; Takiya L; Napatalung L
    J Manag Care Spec Pharm; 2023 Jul; 29(7):848-856. PubMed ID: 37219075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-Mediated and Psychiatric Comorbidities Among Patients Newly Diagnosed With Alopecia Areata.
    Mostaghimi A; Soliman AM; Li C; Barqawi YK; Grada A
    JAMA Dermatol; 2024 Sep; 160(9):945-952. PubMed ID: 39083282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata.
    Ray M; Swallow E; Gandhi K; Carley C; Sikirica V; Wang T; Done N; Signorovitch J; Mostaghimi A
    J Health Econ Outcomes Res; 2022; 9(2):11-18. PubMed ID: 35975139
    [No Abstract]   [Full Text] [Related]  

  • 18. A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization.
    Galván SV; Piraccini BM; Reygagne P; Farrant P; Reed C; Johansson E; Marwaha S; Durand F; Blume-Peytavi U
    Eur J Dermatol; 2023 Dec; 33(6):648-656. PubMed ID: 38465546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Sociodemographic Features of Alopecia Areata in Five Colombian Cities: An Analysis of the RENAAC Registry.
    Pineda JC; Alvis-Zakzuk NR; Moyano-Támara L; Fierro-Lozada J; Cera-Coll C; Celorio-Murillo W; Alvis-Zakzuk NJ; Zapata-Ospina J; Ruiz-Gómez JF; Zakzuk J; Alvis-Guzmán N; Castillo-Molina D
    Actas Dermosifiliogr; 2024 Oct; 115(9):T845-T851. PubMed ID: 39243883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Sociodemographic Features of Alopecia Areata in Five Colombian Cities: An Analysis of the RENAAC Registry.
    Pineda JC; Alvis-Zakzuk NR; Moyano-Támara L; Fierro-Lozada J; Cera-Coll C; Celorio-Murillo W; Alvis-Zakzuk NJ; Zapata-Ospina J; Ruiz-Gómez JF; Zakzuk J; Alvis-Guzmán N; Castillo-Molina D
    Actas Dermosifiliogr; 2024 Oct; 115(9):845-851. PubMed ID: 38395225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.